Bucillamine ((Intravenous)
N/A
Report date: 2025/09/02 17:34:41
Base Information
Drug NameBucillamine ((Intravenous)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRevive Therapeutics LtdUniversity of Waterloo
China Registration ClassN/A
Develop Information
Active CompaniesRevive Therapeutics Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A